Posts by Muana Minkoué
Regenosca closes CHF 1Million pre-seed round
Regenosca closes CHF 1Million pre-seed round to demonstrate endoscopic delivery of TissueSpan implants. Regenosca creates unique bio-implants, enabling the body to attract and organise its own cells for seamless healing. Providing a temporary, naturally absorbed bridge, the TissueSpan technology replaces diseased tissue and restores patients to full health. With access to markets worth…
Read MoreSwiss Venture Capital Report: CHF 1.1 Billion for Swiss startups
Swiss venture capital financing remained at the low level of the previous year in the first half of 2024, with CHF 1’082.4 Million going to 138 financing rounds. Nevertheless, there were also positive signs, such as an increase in investment in the biotech sector. This half-year update to Swiss Venture Capital Report, published…
Read MoreAgora Care raised CHF 2.2 Million
Agora Care, a Campus Biotech-based startup, announced the closing of its round of financing of CHF 2.2 Million This capital increase will help launching a promotional campaign and strategic partnerships in the US market. Furthermore, it will also enable the expansion of patient enrolment in Switzerland and Europe through a new process that…
Read MoreAsceneuron secures $100 Million Series C
Asceneuron secures $100 Million Series C financing to advance groundbreaking therapeutics in neurodegenerative diseases. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, announced a $100 Million oversubscribed Series C financing to advance the clinical development of its groundbreaking clinical pipeline of…
Read MoreCsky.ai Seed closed CHF 1 Million seed round
Swiss Edge AI startup csky.ai has just closed its seed round, exceeding CHF 1 Million of total funding inclusive of equity, grants, and loans raised since the company launch. Among the investors are several Swiss, French and American business angels, the Founderful Fund and two companies. The raised funds are set to take the startup…
Read MoreAspivix among the 15th French American Entrepreneurship Award winners
The French American Entrepreneurship Award (FAEA) has concluded its 15th year by recognizing three exceptional early-stage startups led by French entrepreneurs in the US. Since 2008, the FAEA has supported innovation and growth for these businesses, helping them succeed in the American market. A Jury, comprised of a Panel of Experts and FAEA…
Read MoreCEIDOS secures support from Innosuisse
The BioArk-based startup announced that its innovation project has been approved by the Innosuisse Innovation Council, securing significant funding. With a total of CHF 1.2 Million, CEIDOS will elevate its C-Netics technology in partnership with CSEM and HES-SO Valais-Wallis. This project will enhance the startup on-line monitoring technology, enabling continuous and more precise control…
Read MoreHAYA Therapeutics co-founders win inaugural Andreas & Thomas Struengmann Award
HAYA Therapeutics, SA, announced that HAYA’s Co-Founders Samir Ounzain and Daniel Blessing have received the inaugural Andreas & Thomas Struengmann Award. Recognising entrepreneurial vision and talent in the life sciences among the DACH region, which includes Germany, Austria and Switzerland, the award honours the efforts of Drs. Ounzain and Blessing in creating a…
Read MoreVanarix raised CHF 4 Million to begin new clinical trials
The Biopôle-based startup recently raised CHF 4 Million from private investors to finance new clinical trials and the implementation of Cartibeads automated manufacturing. Founded in 2018, Vanarix is a clinical stage startup specialising in regenerative medicine, focusing on articular cartilage regeneration. Despite being a small team of three people, the startup has already…
Read MoreDandelion Science and the Wyss Center announce AI partnership
The Wyss Center for Bio and Neuroengineering and Dandelion Science announced a partnership focused on a cutting-edge generative AI neuromodulation platform that could speed the development of safe, non-invasive ways of treating neurodegenerative and neuropsychiatric disorders. The platform harnesses the power of generative artificial intelligence (AI) to synthesise, on demand, precision sensory stimulation…
Read More